I am a strong believer QFR® adds invaluable parameters to the diagnostic angiogram. This will move us to one test that will give us all the information.

"Our technology offerings will allow Medis to complement and further enhance its already impressive suite of clinical offerings and spur innovation."

State-of-the-art approach in acute coronary syndrome targets on the "pancoronary risk". This can be assessed easily, safely, and reproducibly by QFR®.